Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

16

Number of overlapping holdings

32.7%

% of FTXH's 51 holdings also in XPH

43.2%

% of XPH's 40 holdings also in FTXH

Overlap by Weight
Sector Drift (FTXH minus XPH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in FTXH
Weight
in XPH
Overlap
MERCK & CO. INC. 7.2% 4.2% 4.2%
JOHNSON & JOHNSON 7.3% 4.0% 4.0%
BRISTOL-MYERS SQUIBB CO 7.0% 3.9% 3.9%
ELI LILLY & CO 3.8% 5.6% 3.8%
PFIZER INC 7.0% 3.8% 3.8%

Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to XPH
ABBVIE INC 7.5%
AMGEN INC 3.7%
CARDINAL HEALTH INC 3.7%
VERTEX PHARMACEUTICALS INC 3.6%
REGENERON PHARMACEUTICALS 3.6%
GILEAD SCIENCES INC 3.6%
BIOGEN IDEC INC 3.5%
PFIZER INC 3.2%
JOHNSON & JOHNSON 3.2%
BRISTOL-MYERS SQUIBB CO 3.0%
FTXH Underweight Relative to XPH
REATA PHARMACEUTICALS, INC. CLASS A -7.9%
ELANCO ANIMAL HEALTH, INC. -5.2%
CATALENT INC -4.6%
AXSOME THERAPEUTICS, INC. -3.9%
ROYALTY PHARMA PLC CLASS A -3.7%
INTRA-CELLULAR THERAPIES INC -3.1%
VENTYX BIOSCIENCES, INC. -3.0%
PERRIGO CO -2.7%
HARMONY BIOSCIENCES HOLDINGS, INC. -2.3%
CORCEPT THERAPEUTICS INC -2.2%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY